Re: "We expect PDS will fund its operations through licensing revenue."

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

shboomer

Rank: Treasurer [?]

Points: 5302 [?]

Votes: 60 Score: 2.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: "We expect PDS will fund its operations through licensing revenue."

in response to

"We expect PDS will fund its operations through licensing revenue."

gcduck

posted on Oct 17, 2011 05:01PM

I would rather have seen "fully anticipate" rather than "expect".

Even better, "Based on expert forensic accounting analysis of PDS and of its associated pipeline of potential licenses, we fully anticipate that PDS will fund its operations through licensing revenue."

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply